ACHV vs GS · $569.1M cap vs P/E 20, rev $58.28B
Achieve Life Sciences Inc (ACHV) versus Goldman Sachs Group Inc (GS) — a side-by-side from cached financials, not a winner call.
Achieve Life Sciences Inc (ACHV) is a biotechnology company listed on NASDAQ.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
ACHV does not have a complete income-statement cache yet.
Latest reported GS revenue for 2025-12-31 was $58.28B. Net income was $17.18B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. GS currently screens at market cap $324.25B and trailing P/E 20.1.
ACHV currently screens at market cap $569.1M. GS currently screens at market cap $324.25B and trailing P/E 20.1.
Not investment advice. Open the ACHV and GS stock pages for the full models.
Not investment advice.